iMD Companies, Inc. (ICBU)
| Previous Close | 0.0053 |
| Open | 0.0053 |
| Bid | 0.0059 x 0 |
| Ask | 0.0060 x 0 |
| Day's Range | 0.0053 - 0.0062 |
| 52 Week Range | 0.0003 - 0.0080 |
| Volume | |
| Avg. Volume | 14,209,752 |
| Market Cap | 24.636M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Mar 09, 2018 - Mar 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireiMD Companies and Its Subsidiary Riize Health Announce Official Product Line Launch of Riize Hair
RANCHO CORDOVA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC:ICBU) and its subsidiary Riize LLC (Riize Health) is pleased to announce the launch of its Riize Hair product line. On Friday, October 25, 2024, Riize Health began selling Riize Hair, an advanced hair loss solution for men, through its telemedicine platform of licensed health care professionals. The proprietary formula in the Riize Hair products combines the most effective FDA approved prescription hair growth ing
- GlobeNewswire
iMD Companies and Its Subsidiary Riize Health Announce New Product Lines: Riize Hair & Riize Weight Maintenance
RANCHO CORDOVA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) subsidiary Riize, LLC (Riize Health) -- announces two new innovative products for the personal healthcare market. Riize Health will begin marketing Riize Hair, an advanced hair loss solution for men. With a proprietary formula, combining minoxidil, finasteride and biotin, the product will come in both topical solution and oral dissolving strip forms. Riize Hair will bring both a new product and treatment ap
